CTOs on the Move

Virginia Mason Medical Center

www.vmmc.org

 
Virginia Mason Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Seattle, WA. To find more information about Virginia Mason Medical Center, please visit www.vmmc.org
  • Number of Employees: 0-25
  • Annual Revenue: $500M-1 Billion
  • www.vmmc.org
  • 1100 9th Ave
    Seattle, WA USA 98101-2756
  • Phone: 206.223.6600

Executives

Name Title Contact Details
Dean Schultz
Chief Information Security Officer Profile

Similar Companies

TrialCard

TrialCard offers customized patient access solutions exclusively for the pharmaceutical industry in support of product marketing, patient assistance programs, and phase IV clinical trials. TrialCard innovates by focusing on client brands and analyzing new trends in prescription optimization for both insured, and uninsured patients.

Sebo Tek Hearing Systems

Sebo Tek Hearing Systems is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

East Tennessee Behavioral Health

East Tennessee Behavioral Health is a hospital and treatment facility for adolescents and adults struggling with mental health concerns such as anxiety disorders, depression, bipolar disorder, and posttraumatic stress disorder (PTSD).

Compass Professional Health Services

Compass Professional Health Services is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.